Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
SynopsisG

Identifying fetal alcohol spectrum disorder in primary care

Christine Loock, Julianne Conry, Jocelynn L. Cook, Albert E. Chudley and Ted Rosales
CMAJ March 01, 2005 172 (5) 628-630; DOI: https://doi.org/10.1503/cmaj.050135
Christine Loock
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julianne Conry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jocelynn L. Cook
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert E. Chudley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ted Rosales
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading
  • © 2005 CMA Media Inc. or its licensors

Fetal alcohol spectrum disorder (FASD) is a term that encompasses the wide range of physical, mental and behavioural effects that can occur when a person is exposed to ethanol during gestation. The diagnoses under the FASD umbrella are fetal alcohol syndrome (FAS), partial FAS (p-FAS) and alcohol-related neurodevelopmental disorder (ARND). The term FASD is not intended for use as a clinical diagnosis.

Like other developmental disabilities, FAS-related conditions require comprehensive assessment by a team of trained specialists. This has left many primary care physicians unclear of their role in making FASD-related diagnoses in clinical practice. This article highlights the salient messages for primary care physicians from a comprehensive guideline on FASD diagnosis that is included with this issue of CMAJ as a supplement and available online at www.cmaj.ca/content/vol172/5_suppl/index.shtml1

Rationale for early diagnosis

Early diagnosis is associated with better long-term outcomes. Targeted interventions in childhood have been shown to reduce the risk for later secondary disabilities, such as dependent living, confinement, and addiction and mental health concerns.2

A diagnosis in early childhood may also serve as a clinical biomarker for unrecognized maternal mental health and addiction concerns and provide an opportunity to offer interventions, support and counselling for the birth mother. This, in turn, may decrease rates of maternal–child separation, facilitate recognition and intervention for other affected siblings, and prevent subsequent children from being similarly affected.3

Therefore, an FASD diagnosis should result in far more than simply providing patients and their families with a label; it should provide the impetus for early developmental interventions, family support and preventive measures to limit subsequent health problems.

The diagnosis of FAS has not been monitored consistently on a provincial or national basis, which has resulted in significant underreporting and, therefore, an inadequate allocation of resources. A standardized interdisciplinary approach to early diagnosis is essential for more accurate surveillance of FASD.4

The FASD diagnostic process

The diagnostic process for FASDs is complex, given the wide range in the type and severity of the possible effects of prenatal alcohol exposure. The best way to ensure an accurate diagnosis is through a comprehensive, multidisciplinary assessment that involves physicians (generally pediatricians, clinical geneticists, psychiatrists or neurologists) and educational psychologists or neuropsychologists, joined by other developmental specialists as indicated by the age or presentation of the patient (e.g., speech or language pathologists, occupational therapists and physiotherapists).

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 1.

The criteria for FASD diagnoses are shown in Table 1 (a formal 4-Digit Diagnostic Code is presented in the supplement). Box 1 outlines the key domains of the central nervous system (CNS) that are assessed in the diagnostic process. Most of the domains are generally tested by registered psychologists, speech or language pathologists or occupational therapists. To make a diagnosis of brain injury, expert consensus has recommended that there be abnormalities in at least 3 domains at 2 standard deviations below that expected in the normal population.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Box 1.

The role of the primary care physician

The primary care physician is involved in screening for alcohol use in pregnant women, referral for diagnosis, follow-up and linking patients to the community resources.

Screening

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Box 2.

Tools for screening for alcohol misuse in women that have been found to be both sensitive and specific include CRAFFT (Box 2) for adolescent women and the modified CAGE (T-ACE and TWEAK; Table 2) for pregnant and nonpregnant women. Additional training to ask questions related to alcohol use during pregnancy in a consistent, sensitive and culturally appropriate manner may be required.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 2.

When a patient is found to be misusing alcohol, the primary care physician is in the ideal role to obtain additional information regarding quantity and maximum frequency of alcohol use, to validate the screening, to provide support and counselling when trained in early brief intervention or motivational interviewing techniques, and to make referrals when indicated. National Institute on Alcohol Abuse and Alcoholism guidelines recommend that any woman who drinks more than 7 drinks per week or more than 3 drinks on any given day in the past month should be further assessed for risk of alcohol-related problems. Recent data suggest that prenatal exposure to small amounts of alcohol — as low as 1 standard drink per day, where a standard drink contains about 0.5 oz of ethanol alcohol (e.g., 360 mL [12 oz.] of beer, 150 mL [5 oz.] of wine or 45 mL [1.5 oz.] of spirits) — has some neurobehavioural effects on the offspring.6 Since the precise lower threshold for ethanol embryopathy is unknown, pregnant women should be advised to abstain from all alcohol use if possible.

Who should be referred for multidisciplinary assessment?

Patients should be referred for assessment in the following situations:

  1. presence of 3 facial anomalies characteristic of prenatal alcohol exposure (see Table 1) and evidence of significant prenatal exposure to alcohol at levels known to be associated with physical and developmental effects;

  2. presence of 1 or more facial anomalies, growth impairment and known or probable significant prenatal alcohol exposure;

  3. presence of 1 or more facial anomalies, 1 or more CNS deficits (see Box 1) and known or probable significant prenatal alcohol exposure;

  4. presence of 1 or more facial anomalies, growth impairment and 1 or more CNS deficits;

  5. CNS deficits and known or probable significant prenatal alcohol exposure.

Accurate identification of facial anomalies characteristic of prenatal alcohol exposure may be challenging for many clinicians (figures showing these anomalies are provided in the supplement). Although it is unnecessary that facial anomalies be identified for patient referral, the family physician's information on pre- and postnatal growth and on maternal health and risk factors for alcohol intake during pregnancy are essential for accurate diagnosis. It is vital, therefore, that the referral include as much information as possible regarding alcohol and other potential teratogen exposure or genetic factors to assist with diagnostic accuracy and to consider and exclude other confounding or comorbid conditions.

Conclusion

The diagnostic assessment for prenatal alcohol exposure is a diagnosis for the affected individual, their mother, and other possibly affected family members. The primary care physician is a catalyst for prevention of continued exposure and subsequent affected siblings, referrals for diagnostic assessment, and links to services and resources to improve outcome.

References

  1. 1.↵
    Chudley AE, Conry J, Cook JL, Loock C, Rosales T, LeBlanc N. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ 2004;172(Suppl 5).
  2. 2.↵
    Streissguth A, Barr H, Kogan J, Bookstein F. Primary and secondary disabilities in fetal alcohol syndrome. In: Streissguth AP, Kanter J, editors. The challenge of fetal alcohol syndrome: overcoming secondary disabilities. Seattle: University of Washington Press; 1997. p. 25-39.
  3. 3.↵
    Astley SJ, Bailey D, Talbot C, Clarren SK. Fetal alcohol syndrome (FAS) primary prevention through FAS diagnosis: II. A comprehensive profile of 80 birth mothers of children with FAS. Alcohol Alcohol 2000;35(5):509-19.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Astley SJ. Diagnostic guide for fetal alcohol spectrum disorders: The 4-Digit Diagnostic Code (3rd edition). Seattle: University of Washington Publication Services; 2004. Available: http://depts.washington.edu/fasdpnhtmls/4-digit-code.htm (accessed 2005 Feb 1).
  5. 5.
    Chang C., Wilkins-Haug L, Berman S, Goetz MA, Behr H, Hiley A. Alcohol use and pregnancy: improving identification. Obstet Gynecol 1998; 91 (6) :892-8.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Sood B, Delaney-Black V, Covington C, Nordstrom-Klee B, Ager J, Templin T, et al. Prenatal alcohol exposure and childhood behaviour at age 6 to 7 years: I. dose-response effect. Pediatrics 2001;108(2):E34.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 172 (5)
CMAJ
Vol. 172, Issue 5
1 Mar 2005
  • Table of Contents
  • Index by author
  • Supplement - Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis
  • Supplément - Ensemble des troubles causés par l'alcoolisation ftale : lignes directrices canadiennes concernant le diagnostic

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Identifying fetal alcohol spectrum disorder in primary care
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Identifying fetal alcohol spectrum disorder in primary care
Christine Loock, Julianne Conry, Jocelynn L. Cook, Albert E. Chudley, Ted Rosales
CMAJ Mar 2005, 172 (5) 628-630; DOI: 10.1503/cmaj.050135

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Identifying fetal alcohol spectrum disorder in primary care
Christine Loock, Julianne Conry, Jocelynn L. Cook, Albert E. Chudley, Ted Rosales
CMAJ Mar 2005, 172 (5) 628-630; DOI: 10.1503/cmaj.050135
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Rationale for early diagnosis
    • The FASD diagnostic process
    • The role of the primary care physician
    • Screening
    • Who should be referred for multidisciplinary assessment?
    • Conclusion
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Detection of Prenatal Alcohol Exposure Using Machine Learning Classification of Resting-State Functional Network Connectivity Data
  • Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan
  • Fetal alcohol spectrum disorder: counting the invisible - mission impossible?
  • Competing Interactions between Micro-RNAs Determine Neural Progenitor Survival and Proliferation after Ethanol Exposure: Evidence from an Ex Vivo Model of the Fetal Cerebral Cortical Neuroepithelium
  • Are FASD guidelines practical and sustainable?
  • Are FASD guidelines practical and sustainable?
  • Google Scholar

More in this TOC Section

  • The changing ecology of avian flu
  • Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
  • A newborn requiring selective bronchial intubation
Show more Synopsis

Similar Articles

Collections

  • Topics
    • Alcohol misuse
    • Pediatrics
    • Reproductive health, infertility & pregnancy

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire